Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...

Kenvue urged the Food and Drug Administration to deny a proposal to add further warnings to acetaminophen products after the ...

Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...

Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

Last month, Trump warned of a link between autism and acetaminophen use in pregnancy, going against advice from medical ...

The maker of Tylenol is pushing back against efforts to change the pregnancy warning on acetaminophen products, saying ...

Kenvue, the maker of Tylenol, defended the safety of the pain reliever as federal health officials prepare to update acetaminophen warning labels following claims that the drug may increase the risk ...

That slump has driven its dividend yield up to more than 5%. While Kenvue stock is down this year, it could soar in 2026.

"Tylenol has been proven to be safe, and I feel like women should be discussing that with their doctors — not hearing it from ...